Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
As of close of business last night, PACS Group Inc’s stock clocked out at $39.77, up 0.66% from its previous closing price of $39.51. In other words, the price has increased by $0.66 from its previous closing price. On the day, 2.07 million shares were traded. PACS stock price reached its highest trading level at $40.0186 during the session, while it also had its lowest trading level at $38.67.
Ratios:
To gain a deeper understanding of PACS’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 17.35 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 15.84. For the most recent quarter (mrq), Quick Ratio is recorded 0.94 and its Current Ratio is at 0.94. In the meantime, Its Debt-to-Equity ratio is 4.19 whereas as Long-Term Debt/Eq ratio is at 3.83.
On December 17, 2024, JP Morgan Downgraded its rating to Neutral which previously was Overweight but kept the price unchanged to $18.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 24 ’25 when Dilsaver Evelyn S bought 16,724 shares for $29.90 per share. The transaction valued at 499,997 led to the insider holds 22,739 shares of the business.
MITCHELL JOHN TODD sold 159,556 shares of PACS for $4,768,379 on Nov 24 ’25. The Chief Legal Officer & Sec. now owns 755,836 shares after completing the transaction at $29.89 per share. On Nov 24 ’25, another insider, John Todd Mitchell, who serves as the Chief Legal Officer of the company, bought 159,556 shares for $27.50 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PACS now has a Market Capitalization of 6171409408 and an Enterprise Value of 9532508160. As of this moment, PACS’s Price-to-Earnings (P/E) ratio for their current fiscal year is 38.35, and their Forward P/E ratio for the next fiscal year is 19.61. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.66. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.21 while its Price-to-Book (P/B) ratio in mrq is 7.15. Its current Enterprise Value per Revenue stands at 1.855 whereas that against EBITDA is 28.03.
Stock Price History:
The Beta on a monthly basis for PACS is -0.63, which has changed by 1.9796381 over the last 52 weeks, in comparison to a change of 0.16067612 over the same period for the S&P500. Over the past 52 weeks, PACS has reached a high of $40.09, while it has fallen to a 52-week low of $7.50. The 50-Day Moving Average of the stock is 55.94%, while the 200-Day Moving Average is calculated to be 167.82%.
Shares Statistics:
It appears that PACS traded 1.52M shares on average per day over the past three months and 1084850 shares per day over the past ten days. A total of 156.62M shares are outstanding, with a floating share count of 41.50M. Insiders hold about 73.50% of the company’s shares, while institutions hold 28.20% stake in the company. Shares short for PACS as of 1765756800 were 3544787 with a Short Ratio of 2.34, compared to 1763078400 on 3357277. Therefore, it implies a Short% of Shares Outstanding of 3544787 and a Short% of Float of 7.66.
